Company Filing History:
Years Active: 2003
Title: The Innovations of Anne Elizabeth Wennerberg
Introduction
Anne Elizabeth Wennerberg is an accomplished inventor based in Ayden, North Carolina. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has the potential to impact cancer research and treatment.
Latest Patents
Wennerberg holds a patent for a monoclonal antibody known as DS6, which targets the tumor-associated antigen CA6. The patent describes methods of use for this antibody, which is selected from a group that specifically binds to the antigen or epitope associated with CA6. This innovation is crucial for advancing therapeutic strategies in oncology.
Career Highlights
Wennerberg is affiliated with East Carolina University, where she conducts her research and development work. Her role at the university allows her to collaborate with other experts in the field and contribute to groundbreaking research initiatives.
Collaborations
One of her notable collaborators is Diane A Semer, who works alongside Wennerberg in her research endeavors. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
Anne Elizabeth Wennerberg's contributions to the field of biotechnology, particularly through her patent on monoclonal antibodies, highlight her role as a significant inventor. Her work continues to pave the way for advancements in cancer treatment and research.